Obligacje
Poniżej znajduje się lista obligacji korporacyjnych Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 5,70% | 100 K | 100,50% | 5,760% | 2037-05-03 | 37,73 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| 5,63% | 5,27 M | 92,46% | 5,150% | 2063-05-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,58% | 41,42 M | 101,68% | 5,700% | 2055-09-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,56% | 1,24 M | 58,75% | 2,900% | 2061-12-10 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,53% | 885 K | 92,46% | 5,000% | 2053-05-17 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,53% | 11,99 M | 80,06% | 4,000% | 2049-03-07 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,49% | 3,52 M | 59,21% | 2,450% | 2050-06-24 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,48% | 0 | 62,28% | 2,750% | 2051-12-10 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,43% | 0 | 79,44% | 3,700% | 2045-02-10 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,40% | 0 | 85,90% | 4,150% | 2043-05-18 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,26% | 36 K | 81,61% | 3,600% | 2042-09-15 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,24% | 180 K | 95,99% | 4,900% | 2044-05-17 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,15% | 0 | 71,44% | 2,350% | 2040-06-24 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 5,06% | 0 | 88,84% | 3,900% | 2039-03-07 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,95% | 146 K | 108,86% | 5,850% | 2039-06-30 | 272,4 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,83% | 472 K | 115,33% | 6,550% | 2037-09-15 | 367,7 M USD | 1 000,00 USD | 2 000,00 USD | Schering-Plough Corp. | |
| 4,81% | 11,21 M | 101,02% | 4,950% | 2035-09-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,79% | 263 K | 108,12% | 5,750% | 2036-11-15 | 340,81 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| 4,50% | 584 K | 113,36% | 6,500% | 2033-12-01 | 651,69 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| XXS282548623MSD Netherlands Capital B.V. 3.75% 30-MAY-2054 | 4,48% | 0 | 88,26% | 3,750% | 2054-05-30 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | MSD Netherlands Capital BV |
| 4,44% | 7 M | 100,40% | 4,500% | 2033-05-17 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,42% | 13,87 M | 100,73% | 4,550% | 2032-09-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,31% | 0 | 88,56% | 2,150% | 2031-12-10 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,21% | 0 | 100,37% | 4,300% | 2030-05-17 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,20% | 1,66 M | 99,08% | 0,750% | 2026-02-24 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,13% | 1,58 M | 100,07% | 4,150% | 2030-09-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,12% | 1,29 M | 88,92% | 1,450% | 2030-06-24 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| XXS282548607MSD Netherlands Capital B.V. 3.7% 30-MAY-2044 | 4,11% | 0 | 94,70% | 3,700% | 2044-05-30 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | MSD Netherlands Capital BV |
| 4,06% | 5,89 M | 97,97% | 3,400% | 2029-03-07 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 4,05% | 0 | 93,86% | 1,900% | 2028-12-10 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 3,92% | 0 | 96,68% | 1,700% | 2027-06-10 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 3,87% | 104 K | 105,90% | 5,950% | 2028-12-01 | 308,19 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| 3,81% | 78 K | 105,63% | 6,400% | 2028-03-01 | 250,78 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| 3,80% | 5,38 M | 100,60% | 4,050% | 2028-05-17 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| XXS282548585MSD Netherlands Capital B.V. 3.5% 30-MAY-2037 | 3,73% | 0 | 97,80% | 3,500% | 2037-05-30 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | MSD Netherlands Capital BV |
| 3,73% | 11,78 M | 100,21% | 3,850% | 2027-09-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| 3,63% | 0 | 79,86% | 1,375% | 2036-11-02 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Merck & Co., Inc. | |
| 3,34% | 0 | 93,62% | 2,500% | 2034-10-15 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Merck & Co., Inc. | |
| XXS282548518MSD Netherlands Capital B.V. 3.25% 30-MAY-2032 | 3,25% | 0 | 100,00% | 3,250% | 2032-05-30 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | MSD Netherlands Capital BV |
| 2,26% | 0 | 99,66% | 1,875% | 2026-10-15 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Merck & Co., Inc. | |
| 1,87% | 20 K | 100,53% | 6,300% | 2026-01-01 | 135,06 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| — | 200 K | 99,00% | 3,681% | 2041-02-06 | 26 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| — | 250 K | 100,46% | 4,675% | 2027-09-15 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Merck & Co., Inc. | |
| — | 195 K | 99,50% | 3,800% | 2041-12-21 | 43,05 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. | |
| — | 107 K | 99,30% | 3,800% | 2040-12-21 | 46 M USD | 1 000,00 USD | 1 000,00 USD | Merck & Co., Inc. |